Research and Markets has announced the addition of the "The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Eastern Europe Edition" report to their offering.
This report is based on the findings of a November 2015-January 2016 survey exploring the views of 93 patient groups in 2015, focusing on differing medical specialties.
The report provides feedback on the corporate reputation of the Eastern-European pharma industry during 2015, as well as the performance of 19 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.
Profiles Of the 19 Companies, According To the Patient Groups in Eastern Europe Familiar with These Companies, or Have Worked With Them
Each profile contains
Company Background Information
- Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
- The profiled company's main treatment subject areas (and areas of R&D).
- A mission statement from the profiled company.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Gedeon Richter
- Merck & Co
- Novo Nordisk
For more information about this report visit http://www.researchandmarkets.com/research/ng4476/the_corporate
View source version on businesswire.com: http://www.businesswire.com/news/home/20161103006270/en/Business Wire
Last updated on: 03/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.